Krystal Biotechincis A Biotechnology Company Based In Pittsburghpennsylvaniafocused On Developing Genetic Medicines For Severe And Rare Diseasesthe Company Specializes In Redosable Gene Therapiesutilizing A Proprietary Technology Platform That Allows For Repeated Administration To Effectively Treat Chronic Genetic Conditions Krystal S Core Technology Features A Modified Hsv 1 Vector Designed For Safe And Localized Gene Deliverythis Innovative Approach Supports Tailored Treatment Regimensenhancing Therapeutic Outcomesthe Companyae S Flagship Productvyjuveka Bercolagene Telserpavec Is The First Fda Approved Redosable Gene Therapy For Dystrophic Epidermolysis Bullosaaddressing Issues Related To Collagen Production In Skin Cellskrystal Also Has A Pipeline Of Investigational Therapies Targeting Various Genetic Disorders In Dermatologyrespiratoryand Systemic Diseases With Two In House Gmp Facilitieskrystal Ensures High Quality Production Of Its Therapiesthe Company Emphasizes A Patient Centric Commercialization Modelfocusing On Accessibility And Engagement With Medical Professionals And Rare Disease Patientskrystal Is Publicly Traded On Nasdaq Under The Ticker Krys
No conferences found for this company.
| Company Name | Krystal Biotech Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
